Altimmune Inc
Stock Chart, Company Information, and Scan Results
$2.77(as of Jul 24, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Altimmune Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$2.77
Ticker SymbolALT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees57
CountyUSA
Market Cap$538.7M
EBIDTA-96.1M
P/E Ratio-3.79
Forward P/E Ratio8.18
Earnings per Share-0.92
Profit MarginUnknown
RSI41.09
Shares Outstanding194.5M
ATR0.14
52-Week High6.44
Volume1,906,900
52-Week Low2.56
Book Value284.0M
P/B Ratio1.21
Upper Keltner3.28
P/S Ratio9,576.65
Lower Keltner2.63
Next Earnings Date08/11/2026
Cash Surplus86.3M
Next Ex-Dividend DateUnknown
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Altimmune Inc In Our Stock Scanner
As of Jul 26, 2026
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.